SFX by Ex Libris Inc.

Title:	Glioblastoma treatment
Source:	Science [0036-8075] Slatkin, D N yr:1994

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Agemy, L. "Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma." Proceedings of the National Academy of Sciences of the United States of America 108.42 (2011): 17450-17455.
description	2.	Ryan, C. "Glioblastoma: Morphologic and Molecular Genetic Diversity." Archives of pathology & laboratory medicine 131.3 (2007): 397-406.
description	3.	Chang, Michael M. "Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme." International journal of radiation oncology, biology, physics 60.2 (2004): 353-357.
description	4.	Vordermark, D. "GAPDH is not regulated in human glioblastoma under hypoxic conditions." BMC molecular biology 8.1 (2007): 55-55.
description	5.	Nelson, Sarah J J. "Imaging glioblastoma multiforme." The cancer journal 9.2 (2003): 134-45.
description	6.	Wen, Patrick Y Y. "Malignant gliomas in adults." New England Journal of Medicine, The 359.5 (2008): 492-507.
description	7.	Malmström, A. "Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial." Lancet oncology 13.9 (2012): 916-926.
description	8.	Ernest, N J. Elsevier, 2009. 877-884.
description	9.	Ruoslahti, E. "Targeting of drugs and nanoparticles to tumors." The journal of cell biology 188.6 (2010): 759-768.
description	10.	Minghua Wu, Chen Huang, Xiayu Li, Xiaoling Li, Kai, G. "LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses." Journal of cellular physiology (2007): 65-74.
description	11.	Miller, G. "BRAIN CANCER: A Viral Link to Glioblastoma?" Science 323.5910 (2009): 30-1.
description	12.	Cotton, F. "The advantage of high relaxivity contrast agents in brain perfusion." European radiology 16 Suppl 7.7 (2006): 16-26.
description	13.	Auerbach, R. "Angiogenesis assays: a critical overview." Clinical chemistry 49.1: 32-40.
description	14.	Jaroszeski, MJ J. "Fundamentals of flow cytometry." Molecular Biotechnology 11.1 (1999): 37-53.
description	15.	Jain, Rakesh K K. "Molecular regulation of vessel maturation." Nature medicine 9.6 (2003): 685-93.
description	16.	Murphy, E. "Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis." Proceedings of the National Academy of Sciences of the United States of America 105.27 (2008): 9343-9348.
description	17.	Brown, A. "Classification of glioblastoma multiforme in adults by molecular genetics." The cancer journal 9.2: 82-90.
description	18.	Engvall, E. "Binding of soluble form of fibroblast surface protein, fibronectin, to collagen." International journal of cancer 20.1 (1977): 1-5.
description	19.	Bolteus, A J J. "Migration and invasion in brain neoplasms." Current neurology and neuroscience reports 1.3 (2001): 225-32.
description	20.	Kubar, A. "Establishment and characterization of a human glioblastoma multiforme cell line." Cancer genetics and cytogenetics 103.1 (1998): 46-51.